Financial Exchange Contracts, Settlement Terms, Expiration

No definition available.

Name:	pymr_FinancialExchangeContractsSettlementTermsExpiration
Namespace Prefix:	pymr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

+ Details

Name:	us-gaap_DerivativeGainLossOnDerivativeNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 25

-Section 50

-Paragraph 1

-Subparagraph (a)(1),(2)

-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

+ Details

Name:	us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_DerivativeLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.

+ References

+ Details

Name:	us-gaap_GainLossOnDerivativeInstrumentsNetPretax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name:	us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Foreign Currency and Other, Net (Details) (USD $)	3 Months Ended		9 Months Ended				3 Months Ended		9 Months Ended		1 Months Ended	9 Months Ended	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended
Foreign Currency and Other, Net (Details) (USD $)	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014 Minimum	Sep. 27, 2014 Maximum	Sep. 27, 2014 Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 28, 2013 Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 27, 2014 Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 28, 2013 Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Jun. 28, 2014 Undesignated hedges: Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 27, 2014 Undesignated hedges: Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 27, 2014 Foreign Currency Gain (Loss)	Sep. 28, 2013 Foreign Currency Gain (Loss)	Sep. 27, 2014 Foreign Currency Gain (Loss)	Sep. 28, 2013 Foreign Currency Gain (Loss)	Sep. 27, 2014 Other Non-Operating Expenses	Sep. 28, 2013 Other Non-Operating Expenses	Sep. 27, 2014 Other Non-Operating Expenses	Sep. 28, 2013 Other Non-Operating Expenses	Sep. 27, 2014 Bridge Loan [Member] Undesignated hedges: Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 28, 2013 Bridge Loan [Member] Undesignated hedges: Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 27, 2014 Bridge Loan [Member] Undesignated hedges: Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]	Sep. 28, 2013 Bridge Loan [Member] Undesignated hedges: Foreign Currency and Other, Net Foreign Exchange Forward [Member] Fair Value Hedging [Member]
Derivative [Line Items]
Foreign currency and other, net	$ (26,588,000)	$ 2,298,000	$ (11,626,000)	$ (22,000)									$ (19,534,000)	$ (274,000)	$ (21,676,000)	$ (1,291,000)	$ (7,054,000)	$ 2,572,000	$ 10,050,000	$ 1,269,000
Option expirations					1 year	5 years
Income realized on financial instrument											18,900,000
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net												5,900,000									0	(2,868,000)	0	(2,868,000)
Derivative, Gain (Loss) on Derivative, Net							$ (5,397,000)	$ 3,410,000	$ 17,031,000	$ 3,899,000												$ 2,900,000